Staphylococcus aureus bacteremia, Australia

Emerg Infect Dis. 2005 Apr;11(4):554-61. doi: 10.3201/eid1104.040772.

Abstract

Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review was undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that approximately 6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Australia / epidemiology
  • Bacteremia / epidemiology*
  • Bacteremia / microbiology
  • Humans
  • Incidence
  • Methicillin Resistance
  • Retrospective Studies
  • Staphylococcal Infections / epidemiology*
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents